(100 days)
Not Found
No
The device description and intended use clearly indicate it is a quality control solution for evaluating the accuracy and precision of hematocrit and metabolite measurements, not a device that performs analysis or interpretation using AI/ML. The "Mentions AI, DNN, or ML" section also explicitly states "Not Found".
No
This device is a quality control system used to evaluate the accuracy and precision of diagnostic tests, not to treat or diagnose a disease.
No
This device is described as a quality control system for evaluating the accuracy and precision of analytical parameters, not for diagnosing conditions in patients. It is used to check the performance of other diagnostic devices.
No
The device description clearly states it is a "two-level quality control system" consisting of "ampoules" containing a "solution." This indicates a physical product, not software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that it is an "assayed quality control system for evaluating the accuracy and precision of all parameters listed on the insert specifying the control ranges." This means it is used in vitro (outside the body) to assess the performance of diagnostic tests.
- Analytes: It lists specific analytes (cGlucose, cLactate, Hct) that are measured in biological samples.
- Device Description: It describes a solution used for quality control, which is a common component of IVD testing workflows.
- Intended User: It is for "professional use," indicating it is used in a laboratory or clinical setting for diagnostic purposes.
The fact that it is a quality control system for evaluating the performance of diagnostic tests for specific analytes makes it fall under the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
This Hematocrit and Metabolite QUALICHECK solution is an assayed quality control system for evaluating the accuracy and precision of all parameters listed on the insert specifying the control ranges.
Analytes are: cGlucose, cLactate, Hct
Product codes (comma separated list FDA assigned to the subject device)
JJS
Device Description
Hematocrit and Metabolite QUALICHECK is a two-level quality control system consisting of:
- Hematocrit and Metabolite QUALICHECK, Level 1 (S7170), 944-039 ●
- . Hematocrit and Metabolite QUALICHECK, Level 2 (S7180), 944-040
The system consists of 30 ampoules per box. One ampoule contains 2 mL of solution.
The quality control solution is an aqueous solution containing an organic buffer, acid, salts, metabolites, and a preservative.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Stability claims are based on real time stability studies. Control solutions are stable for 2 years at 2 °C to 25 °C. Multiple test points were tested, with six measurements at each test point. All study results met the acceptance criteria.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 862.1660 Quality control material (assayed and unassayed).
(a)
Identification. A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.(b)
Classification. Class I (general controls). Except when intended for use in donor screening tests, quality control materials (assayed and unassayed) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three heads facing to the right. The eagle is surrounded by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
May 13, 2015
RADIOMETER MEDICAL ApS METTE HARPSOEE REGULATORY AFFAIRS SPECIALIST AKANDEVEJ 21 2700 BRONSHOJ, DENMARK
Re: K150226
Trade/Device Name: Hematocrit and Metabolite OUALICHECK Regulation Number: 21 CFR 862.1660 Regulation Name: Quality control material (assayed and unassayed) Regulatory Class: I, Reserved Product Code: JJS Dated: March 27, 2015 Received: March 30, 2015
Dear Mette Harpsoee:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
If you desire specific advice for your device on our labeling regulations (21 CFR Parts 801 and 809), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Courtney H. Lias -S
Courtney H. Lias, Ph.D. Director Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K150226
Device Name Hematocrit and Metabolite QUALICHECK
Indications for Use (Describe)
This Hematocrit and Metabolite QUALICHECK solution is an assayed quality control system for evaluating the accuracy and precision of all parameters listed on the insert specifying the control ranges.
Analytes are: cGlucose, cLactate, Hct
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ✓ Prescription Use (Part 21 CFR 801 Subpart D) | ❍ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
1. Submitter and contact information
| Submitter | |
|---|---|
| Company Name: | Radiometer Medical ApS |
| ER Number: | 3002807968 |
| Address: | Aakandevej 21 |
| 2700 Broenshoej | |
| Denmark | |
| Phone: | +45 3827 3827 |
| Fax: | +45 3827 2727 |
Contact Person
| Name: | Mette Skytte Harpsoee |
|---|---|
| Function: | Regulatory Affairs Specialist |
| E-mail: | mette.skytte@radiometer.dk |
| Phone: | +45 3827 3114 |
| Fax: | +45 3827 2727 |
Date prepared
May 7, 2015 Date:
2. a. Device Information
| Device Name: | Hematocrit and Metabolite QUALICHECK |
|---|---|
| Common Name: | Quality Control |
Classification :
| Classification name | CFR Section | Device Class | Product Code |
|---|---|---|---|
| Controls for blood-gases, | |||
| (assayed and unassayed) | 862.1660 | I, reserved | JJS |
2. b. Device Description
Hematocrit and Metabolite QUALICHECK is a two-level quality control system consisting of:
- Hematocrit and Metabolite QUALICHECK, Level 1 (S7170), 944-039 ●
- . Hematocrit and Metabolite QUALICHECK, Level 2 (S7180), 944-040
The system consists of 30 ampoules per box. One ampoule contains 2 mL of solution.
The quality control solution is an aqueous solution containing an organic buffer, acid, salts, metabolites, and a preservative.
4
3 Intended Use
This Hematocrit and Metabolite QUALICHECK solution is an assayed quality control system for evaluating the accuracy and precision of all parameters listed on the insert specifying the control ranges.
Analytes are: cGlucose, cLactate, Hct
4. Predicate device: QUALICHECK5+ (K980135)
Substantial Equivalence
The Hematocrit and Metabolite QUALICHECK is substantially equivalent in Intended Use, fundamental scientific technology, features, and characteristics to the predicate:
510(k) Number/Device Manufacturer:
K980135 QUALICHECK5+, Radiometer Medical ApS
| Similarities | ||
|---|---|---|
| Issue | SE Device | Predicate: QUALICHECK5+ |
| (K980135) | ||
| Form | Same | Liquid |
| Base matrix | Same | Aqueous solution |
| Preservatives | Same | ProClin 950 |
| Parameters | $c$ Glucose, $c$ Lactate, | |
| Hct | pH, pCO2, pO2, $c$ Na+, $c$ K+, $c$ Ca2+, | |
| $c$ Cl-, $c$ Glucose, $c$ Lactate, $c$ tHb, sO2, | ||
| FO2Hb, FCOHb, FMetHb, FHbF, | ||
| $c$ tBil | ||
| Intended Use | This Hematocrit and Metabolite | |
| QUALICHECK solution is an | ||
| assayed quality control system for | ||
| evaluating the accuracy and | ||
| precision of all parameters listed | ||
| on the insert specifying the control | ||
| ranges. | For In Vitro Diagnostic Use. This | |
| QUALICHECK5+ solution is an | ||
| assayed quality control system for | ||
| evaluating the accuracy and | ||
| precision of all parameters listed | ||
| on the insert specifying the control | ||
| ranges. For professional use. | ||
| Storage | 2 °C to 25 °C until expiration date. | 2 °C to 25 °C until expiration date, |
| including up to a total of 15 days | ||
| at up to 32 °C. |
5
| Differences | ||
|---|---|---|
| Issue | SE Device | Predicate: QUALICHECK5+ (K980135) |
| Levels | Two levels | Four levels |
| Target ranges | Target ranges, see Section | |
| 12.02 Target values | Target ranges, see Section 12.02 Target values | |
| Compatible | ||
| analyzers | • ABL77 | |
| • ABL555 | ||
| • ABL605/615/625 | ||
| • ABL80 FLEX | ||
| • ABL80 BASIC | ||
| • EML105 | • ABL5 | |
| • ABL500/505/510/520/555 | ||
| • ABL600/605/610/615/620/625 | ||
| • ABL700/705/710/715/720/725/730/735 | ||
| • ABL805/810/815/820/825/830/835/800BASIC | ||
| • ABL80 - CO-OX | ||
| • ABL80 - OSM | ||
| • ABL90 FLEX | ||
| • EML100/105 |
5. Stability
Stability claims are based on real time stability studies. Control solutions are stable for 2 years at 2 °C to 25 °C. Multiple test points were tested, with six measurements at each test point. All study results met the acceptance criteria.
In-use Stability: The contents should be used immediately after opening.
6. Value Assignment
To determine the true value for each parameter and thereby the assigned values and control ranges for Hematocrit and Metabolite QUALICHECK, the following sampling and measurements are performed:
Hct:
- 6 trays are sampled randomly from the Hematocrit and Metabolite QUALICHECK batch. . Each tray contains 1000 ampoules.
- 5 ampoules are sampled from each of the 6 trays ●
- 30 ampoules are sampled from the reference batch ●
- . Measurements are performed on at least 2 validated ABL555
- Measurements of Hct are performed alternately on the reference ampoule and the sample ampoule. This is repeated 5 times on each ABL555 – 60 measurements in total
- . Measurement results are recorded and analyzed in a validated Excel spreadsheet
6
Glucose and lactate:
- 6 trays are sampled randomly from the Hematocrit and Metabolite QUALICHECK batch. . Each trav contains 1000 ampoules.
- . 5 ampoules are sampled from each of the 6 trays
- 30 ampoules are sampled from the reference batch .
- Measurements are performed on at least 2 validated EML105 ●
- Measurements of glucose and lactate are performed alternately on the reference ● ampoule and the sample ampoule. This is repeated 5 times on each EML105 - 60 measurements in total
- Measurement results are recorded and analyzed in a validated Excel spreadsheet ●
Calculation of true value is described in the test instruction for each level. Assigned values are calculated from the true values by validated algorithms. Control ranges are based on the assigned values ± validated 95% confidence intervals.
7. Conclusion
The Hematocrit and Metabolite QUALICHECK is substantially equivalent in Intended Use, fundamental scientific technology, features, and characteristics to the predicate device: QUALICHECK5+ (K980135).